J Immunother Cancer. 2019 7(1):209. (IF:8.676)
2019-08-12J Immunother Cancer. 2019 Aug 7;7(1):209. doi: 10.1186/s40425-019-0685-y.(IF:8.676). PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity.(PD-1与嵌合抗原受体修饰T细胞的抗肿瘤作用研究)